Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5abf9edac4452b76815dd883cd24f15 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
filingDate |
2008-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bd0e605b7e0a4dac4aa6b40d4f6c0dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c830716e42d7571ac0db53ce1d9a348 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d4e2c6084452ac2528e5897b4dafa01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42418ed2e416333c15745341f2428eb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e5da64d5dc2482b0eb6e049992c3c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b4b9d8657a13650fa2d46be9985475d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e315fea7ec3c13c20df3aad1f4475ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f4088e3fab07c77f0ce31e06a38de7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c23ee0f339ea5792de526afc63487a8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43dacf6d146af98ac8ac0cedda24f55f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e479e6913ee19019f1a98bad43e4ef69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_265e04a8de8129a8894a6b6da3cbe71f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a550621aa74218f68b84c98a2019e1 |
publicationDate |
2009-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2125715-A2 |
titleOfInvention |
Process for the preparation of ezetimibe and derivatives thereof |
abstract |
The present invention relates to the method of preparing of ezetimibe and in particular to novel intermediates for its synthesis and an improved process for preparing such intermediates. Said intermediates may be obtained in high yields and purity in a fast and cost efficient manner. The present invention relates to a novel crystalline form of ezetimibe as well. |
priorityDate |
2007-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |